Skip to main content
padlock icon - secure page this page is secure

Safety of coadministration of ezetimibe and statins in patients with hypercholesterolaemia: a meta‐analysis

Buy Article:

$52.00 + tax (Refund Policy)

Hypercholesterolaemia is a pivotal risk factor for cardiovascular and cerebrovascular disease and is treated with many effective lipid‐lowering agents. Statins are often used alone or in combination with ezetimibe. Combination therapy is more effective because of its complementary approach, which has major benefits for patients with unmanageable lipid levels. Extensive application of combination therapy has resulted in an increased incidence of side‐effects, which has raised our concern.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: adverse event; ezetimibe; hypercholesterolaemia; meta‐analysis; statin

Document Type: Research Article

Publication date: May 1, 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more